Sussex Pathology Network to Deploy Clinisys Laboratory Information System

ClinisysThe Sussex Pathology Network has chosen Clinisys for a laboratory information system (LIMS) that will help its labs to collaborate, building on the supportive relationship that developed during the COVID-19 pandemic.

A single, hosted instance of WinPath Enterprise will replace the existing four live LIMS systems in use at the three trusts and seven laboratories within the network, of which two are at the end of their life.

The replacement of these LIMS systems is crucial to ensure that the labs maintain their capability to deliver a comprehensive range of pathology services, supporting vital aspects such as diagnosis and treatment decisions, blood transfusion, and trauma care.

An implementation team will work alongside laboratory and IT staff to make sure the new LIMS also supports consistent, efficient, and high-quality processes - so clinicians and patients receive the same service, wherever they work or live.

Emily Gaskell, programme director, pathology, at NHS Sussex, said: "During the Covid-19 pandemic, our pathology laboratories worked more closely together, and that encouraged us to move forward and adopt the NHS England model for pathology networks.

"However, because most of the labs are spread along a long, thin, coastal patch, with very poor road communications, a hub and spoke model for all work is impractical.

"Instead, we want to focus on creating a consistent pathology service, so it doesn't matter whether you get a test in Rye or in Chichester; you will get the same test, and the same quality of results, in the same appropriate timeframe.

"To do that, one LIMS is essential. We see Clinisys WinPath as a key enabler for the network, and critical to improving services for people in Sussex."

The Sussex Pathology Network serves three trusts: East Sussex Healthcare NHS Trust, University Hospitals Sussex NHS Foundation Trust, and Queen Victoria Hospital NHS Foundation Trust.

The two acute trusts; East Sussex Healthcare NHS Trust and University Hospitals Sussex NHS Foundation Trust serve a population of around 2.3 million people, while Queen Victoria Hospital provides specialist burns and plastic surgery to a much larger population covering Sussex, Kent, Surrey and parts of South London.

Across the three trusts more than 7 million tests are carried out each year, and demand is growing by 5% per year. WinPath Enterprise will provide a stable, safe and secure platform for these essential services.

It will also enable better communications so laboratories can share workload and expertise, and support remote working. And, in time, it will enable the introduction of automation and AI technologies, so highly trained pathologists can focus on urgent and complex cases, where their expertise is most needed.

Emily Gaskell said: "This is not the only project that the network has on. We also need to deliver our business-as-usual service, invest in our operating model and workforce, and secure new equipment and communications.

"But we are very keen to progress. The new LIMS is an important first step towards our vision for all clinicians, patients and residents across Sussex to have access to a seamless pathology service, with the right test in the right place at the right time - every time."

Implementation is at an early stage, but the aim is to roll-out the new LIMS site by site, and to have the first two sites live by December next year.

Felice Di Rienzo, professional services director at Clinisys said: "We are delighted to be working with the Sussex Pathology Service on the deployment of this new LIMS. The project team want to work at pace, and we are absolutely up for that.

"We look forward to standing alongside the implementation team and the network's clinicians as they roll-out Clinisys WinPath as a stable, secure and safe platform for pathology services today and in the future."

About Clinisys

Clinisys enables healthier and safer communities as a global provider of intelligent diagnostic informatics solutions and expertise that redefine the modern laboratory across healthcare, life sciences, public health and safety. Millions of laboratory results and data insights are generated every day using Clinisys' platform and cloud-based solutions in over 3,000 laboratories across 34 countries.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...